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ABSlRACT  Taxol  is  a  low  molecular  weight  plant  derivative  which  enhances  microtubule 
assembly in vitro and has the unique ability to promote the formation of discrete microtubule 
bundles  in cells.  Tritium-labeled  taxol binds directly to microtubules  in vitro with a stoichi- 
ometry approaching one (Parness, J., and S. 8. Horwitz, 1981, J. Cell Biol.  91:479-487). We now 
report studies in cells on the binding of [aH]taxol and the formation of microtubule  bundles. 
[aH]Taxol  binds to the macrophagelike  cell  line, J774.2, in a specific and saturable  manner. 
Scatchard analysis of the specific binding data demonstrates a single set of high affinity binding 
sites. Maximal binding occurs at drug concentrations which produce maximal growth inhibition. 
Conditions which  depolymerize  microtubles  in  intact  and  extracted cells  as determined  by 
tubulin immunofluorescence  inhibit the binding of [aH]taxol. This strongly suggests that taxol 
binds specifically to cellular  microtubules.  Extraction with 0.1% Nonidet P-40 or depletion of 
cellular ATP by treatment with 10 mM NaNa prevents the characteristic taxol-induced bundle 
formation. The binding of [aH]taxol, however, is retained under these conditions. Thus, there 
must be specific cellular mechanisms  which are required for bundle formation, in addition to 
the direct binding of taxol to cytoplasmic microtubules. 
Taxol,  a  novel diterpenoid, was  originally isolated from the 
stem bark of the western yew, Taxus brevifolia, and has been 
found also in the leaves, stems and roots of a variety of other 
Taxus species (35, 63). The drug is a complex ester, shown to 
be a taxane derivative containing a rare oxetan ring, and is the 
first compound of this type to have antileukemic and tumor 
inhibitory properties.  Early work  in  our  laboratory demon- 
strated that  the drug inhibits replication of HeLa cells (47). 
Studies with P-388 cells taken from taxol-treated mice identi- 
fied taxol as a mitotic spindle poison (22). 
Studies in vitro have shown that in marked contrast to other 
antimitotic drugs, taxol enhances  both the rate and  yield of 
microtubule assembly. The critical concentration of microtu- 
bule protein required for assembly is reduced, and the micro- 
tubules formed are stable to depolymerization by calcium or 
cold (47).  Taxol  also assembles tubulin under  conditions in 
which polymerization would not normally occur. These include 
the absence of microtubule-associated proteins, 36S tubulin- 
containing  ring  structures,  exogenously  added  guanosine  5' 
triphosphate, or organic buffer (27, 50).  Taxol induces micro- 
tubule assembly even at low temperatures (24, 47, 60). Micro- 
tubules assembled to steady state and then incubated with taxol 
become resistant to depolymerization by calcium, suggesting 
that there is a taxoi-binding site on the microtubule. Maximal 
effects in vitro are seen at taxol concentrations stoichiometric 
with the tubulin dimer concentration (49).  Recent work with 
[3H]taxol confirms that the drug does bind to the microtubule, 
and that such binding occurs with a stoichiometry approaching 
one (41). 
HeLa cells incubated with taxol accumulate in the G2 and 
M  phases  of the  cell cycle. In contrast to  cells treated with 
colchicine or vinblastine, these taxol-treated cells exhibit an 
unusual  microtubule cytoskeleton as seen by tubulin immu- 
nofluorescence and electron microscopy. These taxol-cytoskel- 
etons are characterized by the presence of discrete bundles of 
microtubules (18, 48). Treatment with taxol stabilizes cellular 
microtubules to depolymerization by cold, steganacin (48, 49) 
and colchicine (12). The effects of taxol have been studied in 
a  number  of different systems  including mouse  dorsal root 
ganglion-spinal cord cultures (33), Xenopus laevis eggs (25), the 
trypanosome,  Trypanosoma  cruzi  (5), and a  variety of mam- 
malian tissue culture systems (2, 3, 8,  14, 17, 18, 38, 46, 55, 61). 
In all cases examined, the effects of taxol appear to be related 
to the tubulin-microtubule system. 
We report here that [~H]taxol binds to the macrophagelike 
cell line, J774.2, in a specific and saturable manner. Conditions 
which depolymerize microtubules in intact and extracted cells 
inhibit the binding of taxol; this suggests that taxol binds to 
cellular microtubules.  Further,  we  are  able  to  demonstrate 
binding of [~H]taxol under conditions in which taxol-induced 
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conditions are necessary for bundle formation. A preliminary 
report of this work has been presented (32). 
MATERIALS  AND  METHODS 
Drugs 
Taxol  was obtained  from the  National  Cancer  Institute  (Bethesda,  MD), 
podophyllotoxin from Aldrich Chemical Co. (Milwaukee, Wl), and VP-16-213 
from Sandoz (Hanover, N J). Unless otherwise noted, all other drugs and chem- 
icals were obtained from Sigma Chemical Co. (St. Louis, MO). Lumicolchicine 
was prepared by the  method  of Wilson  and  Friedkin  (65).  1 ml of  10  -2  M 
colchicine in 95% ethanol was placed in a quartz cuvette positioned 2 in from a 
long wave Model  UVSL-58 ultraviolet light source (Ultraviolet Products, San 
Gabriel, CA) for 7 h. Completion of the reaction was verified by diluting samples 
to 3  ×  10  -s M  in 95% ethanol and determining ultraviolet spectra on a  Carey 
Model 14R recording spectrophotometer (Applied Physics, Monrovia, CA) using 
cuvettes with a  l-cm light path. 
[3H]Taxol was prepared as previously described (41). Aliquots of a  10  -:~ M 
stock solution in methanol were dried under vacuum and dissolved in dimethyl 
sulfoxide (DMSO)  to a  specific activity of 0.25  Ci/mmol.  Labeled drug was 
stored at -20°C and used within 1 mo of dilution. Purity of [:3H]taxol was >95% 
as determined by silica gel thin-layer chromatography (41). 
Lumicolchicine was stored in 95% ethanol; other drugs were kept as stock  t 
solutions in DMSO. The  final concentration of DMSO  had no effect on cell 
morphology, binding of [3H]taxol or the microtubule display seen  by tubulin 
immunofluorescence in control cells. In general, we find that taxol is insoluble in 
aqueous solutions at concentrations >50 ~M. 
Cells 
The  continuous  macrophagelike cell  line,  J774.2  (37,  44),  was  grown  in 
complete medium consisting of Dulbecco's modified Eagle's medium (DME) 
supplemented with penicillin, streptomycin, 1% glutamine, 1% nonessential amino 
acids, and 20% heat-inactivated horse serum. The cells were grown in monolayer 
at  37°C  in  a  humid incubator (Forma  Scientific, Div.  of Mallinckrodt, Inc., 
Marietta, OH) with an air mixture containing 8% CO~.  All cell culture media, 
sera,  and solutions described herein  were obtained  from Gibco Laboratories 
(Grand Island Biological Co., Grand Island, NY). 
Cells for growth curves were plated at a density of 1 ×  10  ~ cells/ml in 35-ram 
tissue culture dishes. 24 h  later, fresh complete medium plus drug was added. 
After appropriate time intervals, the medium was aspirated. Cells were incubated 
in 1.0 ml of Trypsin/EDTA solution for 10 min at 37°C, 0.5 ml of a 0.4% Trypan 
blue solution was added, and samples counted in a  Bright-Line hemacytometer 
(American Optical Corp., Buffalo, NY). 
Quantification  of [aH]Taxol Binding 
The assay was generally performed on confluent 35-ram tissue culture dishes. 
For J774.2 this typically represented  -4  x  10  °  cells/dish  or  -I  mg protein. 
Before assay, 2 ml of fresh complete medium containing the appropriate drugs 
was added to each dish. Incubations were performed for the appropriate time 
intervals at 37°C. At the end of the assay, the medium was removed and each 
dish was washed five times with ice-cold Dulbecco's phosphate-buffered saline, 
pH 7.4, without calcium or magnesium (PBS) (20). There was no change in the 
amount of label remaining with further washes. Washed ceils were lysed in 1 ml 
of 0.1 N NaOH at room temperature for 12 h. Protein determinations were made 
using the method of Lowry et al. (31). Samples for counting were neutralized 
with an equal volume of glacial acetic acid, added to 20 ml of ACS II (Amersham, 
Arlington Heights, Ill.),  and radioactivity was determined in a  Model  SL4000 
liquid scintillation counter (Intertechnique, Plaisir, France). The external stand- 
ards ratio method was used to convert counts per minute to picomoles of taxol. 
Efficiency of counting averaged 35%. 
Specific binding was calculated as the difference between binding of ['qH]taxol 
in the presence and absence ofa lO0-fold excess of unlabeled taxol. Nonspecific 
binding was determined as binding of [~H]taxol in the presence of a  lO0-fold 
excess of unlabeled taxoL 
Cytoskeletons 
Cytoskeletons were prepared by two sequential detergent extractions. Ceils 
were  plated  in  35-ram tissue  culture dishes  and washed twice with  2  ml of 
stabilizing buffer (SB) (40), containing 0.1  M  piperazine-N,N'-bis(2-ethane  sul- 
fonic acid) (PIPES), pH 6.9, 1 mM ethyleneglycol-bis-(fl-aminoethyl  ether) N,N'- 
tetraacetic acid (EGTA), and 4% polyethylene glycol 6000 (Baker, Phillipsburg, 
NJ).  Cells were incubated for 5 min at 37°C with  1 ml of SB containing 0.1% 
Nonidet P-40 (NP-40), followed by washing twice with 2 ml of SB. The extraction 
and subsequent washings were repeated, [:~H]taxol plus any additions were made 
in SB and [3H]taxol binding to cytoskeletons was done in the same manner as 
with  intact  cells,  except  that  the  final washes were  done  with  SB  at  room 
temperature. 
Immunofluorescence 
Goat antitubulin which had been purified on a  tubulin affinity column was 
kindly provided by Dr.  Felicia Gaskin (Albert Einstein College of Medicine). 
Rhodamine or fiuorescein conjugated rabbit anti-goat antibody was obtained 
from N. L. Cappel Laboratories (Cochranville, PA). The fluorescein conjugate 
produced sharper images. 
Ceils were plated on sterile glass cover slips in 35-mm petri dishes, at a density 
of 2.5 ×  10  ~ cells/ml, and used within 24 h. All operations unless otherwise noted 
were performed at room temperature. The cells were extracted twice as described 
above, and then fixed for 20 rain in 3.7% formaldehyde (Mallinckrodt, Inc., Paris, 
KY)  in  PBS.  Cover slips  were  washed  twice  in  PBS,  plunged into  absolute 
acetone at -20°C for 5 rain, and subsequently washed in PBS. Incubation with 
20/~1 of undiluted goat antitubulin antibody was for 45-60 min in  a  humid 
atmosphere  at  37°C.  Cover  slips  were washed  extensively in  PBS  and  then 
incubated with  20 ~tl of the  fluorescent conjugated rabbit anti-goat antibody 
( 1:1130  dilution) for 45-60 min at 37°C. Cover slips were again extensively washed 
in PBS and then mounted using Aqua-mount (Lerner Laboratories, New Haven, 
CT) on clean microscope slides. A Zeiss (Oberkochen, W. Germany) standard 14 
microscope equipped with epifluorescent optics was used to view the preparations. 
The combination ofa ×  10 ocular lens and a ×  63 oil immersion lens (numerical 
aperature, 1.4) gave a depth of field of 0.8 ttm. Photographs were then taken on 
Plus-X pan 35mm film (Kodak,  Rochester, NY)  using an ASA of 1,000;  the 
meter on the microscope gave exposure times ranging from 15-30 s.  Film was 
developed in Kodak HC-100 (Dilution B) and printed on Kodabromide F4 grade 
paper (Kodak, Rochester, NY). 
Determination of A TP Levels 
Confluent 35-mm dishes of J774.2 were incubated for 60 min at 37°C in 2 ml 
of SB  -+  10 mM NaN.~. The dishes were extracted and ATP levels determined 
according to  Loike et  al. (30).  Luciferin-luciferase was obtained  from Sigma 
Chemical Co. A  standard curve in the range of 10  -7 to  10  -9 M  ATP was used; 
dilutions were made from a  10  -5 M stock solution in 0.04 M Tris-borate, pH 9.2, 
and calibrated by absorption measurements (~sa =  1.54 x  104/M/cm). 
RESULTS 
Binding of [ 3H]Taxol Is Specific and Saturable 
Specific  binding  is  defined  as  that  fraction  of the  total 
binding which is inhibited  by an excess  of unlabeled  ligand. 
The  total,  and therefore  specific,  binding  of [aH]taxol  to the 
macrophagelike  cell  line,  J774.2,  saturates  within  45  min  at 
37°C.  The nonspecific component, which is binding that can 
not be diluted even with a  100-fold excess of unlabeled taxol, 
saturates  sooner, generally within  15 min (Fig.  1 a). Both total 
and  nonspecific  binding  persist  for  at  least  8  h  (Fig.  I b). 
Unlabeled taxol specifically dilutes the binding of [3H]taxol  in 
a concentration-dependent  manner to a level already defined 
as nonspecific binding. A  100-fold excess of unlabeled drug is 
used  in  all  subsequent  experiments  to determine  nonspecific 
binding.  The presence  of serum has no effect  on the specific 
binding  of  [aH]taxol;  thus,  experiments  were  performed  in 
complete  medium  containing  20%  horse  serum.  Nonspecific 
binding, on the other hand, is inhibited by increasing concen- 
trations of horse serum;  the  nonspecific  binding of [ZH]taxol 
will vary depending on the particular concentration and lot of 
serum used. 
Specific binding of [3H]taxol  to J774.2 saturates in a concen- 
tration-dependent manner. Maximal binding occurs at 21 pmol 
bound/mg total cellular protein; half-maximal binding occurs 
at  0.08/~M.  As to be expected,  nonspecific  binding increases 
linearly in a  concentration-dependent  manner,  ranging from 
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(A)  Binding  of  [3H]taxol  to  J774.2 saturates within  60 
min. Confluent 35-ram dishes of 1774.2 were incubated for various 
time intervals at 37°C in 2 ml of complete medium containing 0.3 
/,tM [3H]taxol +  30/LM unlabeled taxol. Cells were washed five times 
with  2  m(  of  ice-cold  PBS, and  lysed  in  1  ml  of  0.1  N  NaOH 
Radioactivity and  protein  concentration  were  determined  as  de- 
scribed  in Materials and Methods. Total binding was measured in 
the  presence  of  0.3  /,tM  [3H]taxol  (@). Nonspecific  binding  was 
measured by simultaneous addition of 0.3/~M  [3H]taxol and 30 ~M 
unlabeled taxol (O). (B) Binding of [3H]taxol to J774.2 persists for at 
least 8 h. The experiment was performed as in  A, except for longer 
time intervals. 
25% of total binding at 0.01 btM to 45% at 0.4 #M (Fig. 2 a). 
Scatchard  analysis  of the  specific  binding  data  produces  a 
linear plot,  indicating a  single set of binding sites  (Fig. 2 b). 
Taking into consideration the limitations discussed by Weisiger 
et  al.  (64)  in  applying such  analysis to binding  in  cells,  we 
calculate 4.8 ×  I0  ° sites/cell and a dissociation constant of 0.2 
/~M. Binding is unaffected by varying cell density in the range 
of 1 x  108 ceUs/ml to 2 x  108 cells/ml. 
Binding of [3H]Taxol Correlates with Growth 
Inhibitory Effects 
The 50% effective lethal dose (LD~o) for taxol in the J774.2 
cell line at 48 h  is ~5  x  10  -8 M; this correlates well with the 
half-maximal binding concentration of 8 x  10  -8 M  (Fig. 2 a). 
Further, maximal growth inhibition of J774.2 occurs at taxol 
concentrations which produce maximal binding (Fig. 3). 
Effect of Simultaneous  Addition of Mitotic 
Inhibitors on Binding of [ 3H]Taxol 
Simultaneous addition of [3H]taxol  and a  100-fold excess of 
either colchicine, podophyllotoxin, vinblastine, nocodazole, or 
unlabeled  taxol completely inhibits  specific binding (Fig. 4). 
Griseofulvin, an antimitotic agent whose mechanism of action 
is  still  controversial,  but whose cellular  activity may not be 
mediated  by microtubule depolymerization (11,  23), does not 
inhibit  the binding of [SH]taxol.  Lumicolchicine and VP-16- 
213, congeners of colchicine and podophyllotoxin, respectively, 
which do not interact with  tubulin  (29,  66) are also without 
effect. 
Mitotic inhibitors such as colchicine and podophyllotoxin at 
concentrations greater  than  those  that  block cells  in mitosis 
have been shown to also inhibit  the transport of nucleosides 
across  the  cell  membrane.  The  tubulin-inactive  congeners, 
lumicolchicine and VP-16-213, retain the transport inhibitory 
properties of their parent compounds (29, 67), but nevertheless 
do  not  inhibit  the  binding  of [3H]taxol.  This  suggests  that 
inhibition of [3H]taxol  binding by colchicine and podophyllo- 
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FIGURE  2  (A) [3H]Taxol binds 1774.2 in a saturable manner. Conflu- 
ent 35-mm dishes of 1774.2 were incubated for 60 rain at 37°C  in 
2  ml  of  complete  medium  containing  various  concentrations  of 
[3H]taxol. Cells were washed five times with 2 ml of ice-cold  PBS, 
and lysed in 1 ml of 0.1 N NaOH. Radioactivity and protein concen- 
tration  were determined  as described  in  Materials and  Methods. 
Specific binding (0) is calculated as the difference between binding 
of  [3H]taxol  in  the  presence and  absence of  a  100-fold  excess  of 
unlabeled taxoL Nonspecific binding (©)  is binding of [3H]taxol in 
the presence of a 100-fold excess of unlabeled taxol. (B) Scatchard 
analysis reveals a single class of specific binding sites  for [3H]taxol 
in J774.2. The specific  binding data from  A  have been plotted  in 
the appropriate Scatchard  analysis form  (45).  The  line was deter- 
mined by a least squares linear regression. Units on the abscissa  are 
pmol  [3H]taxol/mg  protein.  Units  on  the ordinate are pmol  [3H] 
taxol/mg protein//zM. 
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FiGure  3  Maximal specific  binding to J774.2 occurs  at taxol con- 
centrations  which  produce  maximal  growth  inhibition.  A  growth 
curve of J774.2 incubated  for 48 h  with  various concentrations of 
taxol was performed as described in Materials and Methods. Percent 
control  growth  01L)  is  plotted.  The  specific  binding  data  from 
Fig. 2 A, presented as percent maximal binding (@) is also shown. A 
maximal binding of 0.4 b~M [3H]taxol was used. 
toxin is microtubule-specific and is not related to the ability of 
these drugs to inhibit nucleoside transport. 
The binding results are compatible with observations made 
with tubulin immunofluorescence. Although they are a cloned 
line, J774.2 cells exist in culture in a wide variety of shapes and 
sizes. Its tubulin cytoskeleton (34), similar to that of  the primary 
macrophages  (21,  42),  is  characterized  by  a  single  distinct 
microtubule organizing center (MTOC) from which all micro- 
tubules in the cell appear to emanate. Treatment with 0.3 #M 
[3H]taxol for 60 min does not affect this organization (Fig. 5 a); 
this display is identical to that of a control cell. 
Simultaneous addition of 30/~M  podophyllotoxin and  0.3 
#M [3H]taxol,  however, results in a complete loss of this char- 
acteristic  microtubule  display  (Fig.  5  c);  specific binding  of 
[3H]taxol is inhibited. Its congener, VP-16-213, does not affect 
binding  nor  the  cytoskeletal  display.  Griseofulvin,  likewise, 
affects neither microtubule immunofluorescence, nor binding 30 
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FiGUre  4  Effect  of simultaneous addition of mitotic inhibitorson 
binding of  [3H]taxol to  1774.2. Confluent  35-ram  dishes of  1774,2 
were  incubated  for 60  rain  at  37°C in  2  ml  of complete medium 
containing various concentrations of [3H]taxol and a 100-fold excess 
of a mitotic inhibitor. Cells were washed five times with 2 ml of ice- 
cold PBS,  and lysed in I  ml of 0.1 N NaOH. Radioactivity and protein 
concentrations  were  determined  as  described  in  Materials  and 
Methods. (II) Lumicolchicine. (0) Griseofulvin. (Q) Control. (A) VP- 
16-213. (©)  Taxol. (×)  Nocodazole. (O)  Vinblastine.  (A)  Podophyl- 
lotoxin. ([Z]) Colchicine. 
of [3H]taxol.  Simultaneous  treatment  with 30 ttM vinblastine 
and  0.3  #M  [3H]taxol  results  in  a  disruption  of cytoskeletal 
structure  and  the  formation of numerous well-defined  para- 
crystals (Fig. 5 d). Since the binding of [3H]taxol is inhibited in 
these preparations,  vinblastine-induced  paracrystals must not 
bind taxol. Hence, the taxol-binding site present on one poly- 
meric form, the microtubule, is absent from another,  the vin- 
blastine-induced paracrystal. 
Microtubule  disassembly  causes  a  rapid,  characteristic 
change in the cell shape of a variety of leukocytes, including 
this particular cell line, J774.2.  Treatment with agents such as 
colchicine or podophyllotoxin induces the formation of a large 
bulge  or  protuberance  in  the  cytoplasm  of these  cells  (34). 
These can readily be seen here (Fig.  5 c and d).  Vinblastine- 
induced paracrystals appear to be excluded from the protuber- 
ance.  This  is  presumably due to their  displacement  by actin 
filaments which are concentrated in these regions (1). 
Unlabeled taxol, as expected, does not destroy the microtu- 
bule cytoskeleton (Fig. 5 b), but completely inhibits the binding 
of [3H]taxol.  It should be noted, however, that a  30 gM incu- 
bation  with  taxol  for 60  min  does  induce  the  formation  of 
FIGURE  5  Tubulin immunofluorescence of J774.2 cells which  have been treated with  [aH]taxol and a lO0-fold excess of various 
inhibitors. Cells were incubated for 60 rain at 37°C in complete medium containing 0.3/zM  [3H]taxo[ alone (A) or labeled drug 
plus  30 /LM  unlabe(ed  taxol  (B),  plus  30 #M  podophyllotoxin  (C),  or  plus  30 p.M  vinblastine  (D).  Cells  were  processed  for 
immunofluorescence as described in Materials and Methods. The arrows in  C and  D  point to the limits of the protuberance seen 
after the appropriate treatment. Bar, 20/xm. 
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with  a  microtubule  organizing  center,  which  can  easily  be 
identified in control ceils (see Fig.  5 a). Taxol-induced bundle 
formation  independent  of an  MTOC  has  been  observed  in 
other systems (18, 55). 
Effect of Pretreatment with Mitotic Inhibitors on 
Binding of [ 3H]Taxol 
Pretreatment with  3.0 #M  nocodazole  for 2  h  followed  by 
washing and incubation with 0.3 #M [3H]taxol results in bind- 
ing similar to that of control ceils (Table I). When these ceils 
are examined  by tubulin  immunofluorescence,  a  microtubule 
cytoskeleton is  observed  (Fig.  6 b).  This  is  probably  because 
the effects  of nocodazole are readily  reversible (15,  56).  The 
effects  of  other  antimitotic  drugs,  however,  are  less  so;  for 
example, the binding of colchicine to tubulin in vitro is essen- 
tially  irreversible  (4,  66).  Pretreatment  with  colchicine,  col- 
cemid or vinblastine, followed by washing, results in inhibition 
of [3H]taxol binding (Table I). Immunofluorescence of colchi- 
cine-reversed cells reveals the complete loss of all microtubule 
structure,  and  formation  of  the  characteristic  protuberance 
(Fig. 6 a). Similar observations can be made with vinblastine- 
reversed ceils; treatment with 3 #M vinblastine does not cause 
paracrystal  formation  under  these  conditions.  The  microtu- 
bule-depolymerizing effects of 3 #M colcemid are not reversible 
in  J774.2  cells  as  seen  by  tubulin  immunofluorescence  and 
binding of [3H]taxol. Other laboratories have used colcemid as 
a  reversible  antimitotic  agent,  but  those  experiments  were 
performed at lower drug concentrations with other cell types 
(7, 39, 58). 
As seen in Fig. 6 b, cells pretreated with nocodazole, washed, 
and  then  incubated  with  0.3  #M  [3H]taxol  for  60  min  form 
bundles  of  microtubules  which  are  not  associated  with  an 
organizing center. This differs from what is seen when 0.3 #M 
taxol  is added  directly to a  control cell,  where  at  60  rain  no 
alteration in the tubulin cytoskeleton is seen (Fig. 5 a). Similar 
results have been reported by others (18, 55). 
Effect of Sodium Azide Treatment on Binding of 
[ 3H]Taxol 
Pretreatment of ceils with 10 mM NaNa for 60 min at 37°C 
depletes  cellular  ATP  levels  but  has  no  effect  on  either  the 
specific  or  nonspecific  binding  of [3H]taxol  (Table  II).  Such 
azide treatment likewise has no effect on the organization of 
FIGURE  6  Tubulin  immunofluorescence  of J774.2  cells which  have 
received  various  pretreatments  before  [3H]taxol  incubation.  Cells 
were  pretreated  in  complete  medium  containing  3/IM  colchicine 
(A) or 3 #M  nocodazole  (B)  for 120 rain  at 37°C.  This  medium  was 
aspirated;  the  dishes  were  then  washed  five  times  with  DME  at 
room  temperature  and  subsequently  incubated  with  0.3 ~M  [3H]- 
taxol  in complete  medium  for 60 rain at 37°C. Cells were processed 
for  immunofluorescence,  as  described  in  Materials  and  Methods. 
The arrows  in  A  point  to the  limits  of the protuberance  seen  after 
colchicine  pretreatment.  Bar, 20 #m. 
TABLE I 
Effect of Various Pretreatments on Binding of [~H]Taxol to 
1774.2 Cells 
Pretreatment  Nonspecific  Specific 
pmol/  mg protein  pmol  / mg protein 
0.3% DMSO  21,4 +  1.1  26.2 +_ 3.6 
3/LM Colchicine  18.0 =1= 1.7  <1.0 
3 #M Colcemid  22.4 +  1.9  <1.0 
3/~M Vinblastine  19.6 +  2.0  <1.0 
3/~M Nocodazole  19.3 +  1.1  20.4 =1= 4.7 
Confluent 35-mm dishes of 1774.2  were pretreated as indicated for 120 min at 
37°C in 2 ml of complete  medium. Cells were then washed five times  with 2 
ml  of  DME at  room  temperature  and  subsequently  incubated  with  0.3 /~M 
[3Hltaxol +  30/zM unlabeled taxol in 2 ml of complete medium for 60 min at 
37°C, Cells were washed five times with 2 ml of ice-cold  PBS, and lysed in 1 
ml of 0,1 N NaOH. Radioactivity and protein concentration were determined 
as described  in  Materials and  Methods. Values  are the average of triplicate 
determinations ±  one standard deviation. 
TABLE  II 
Effect of Sodium Azide Treatment on Binding of [aH]Taxol to 
1774.2 Cells 
Nonspe- 
cific  Specific  ATP  level 
pmol/mg  pmol/mg 
protein  protein  pmol/plate 
--10 mM Sodium  azide  21,2 =t= 1,1  24.8 =1= 2.9  48.4 +  0.2 
+10 mM Sodium  azide  24.7 ±  2.6  20.3 +  2.2  2.0 ±  0.1 
Confluent 35-mm  dishes of 1774.2 were incubated for 60 rain at 37°C in 2 ml 
of stabilization buffer (SB) +  10 mM NAN,. This buffer was then removed and 
2  ml  of  fresh  SB  ±  10  mM  NaN3  containing  0.3  p,M  [3H]taxol  ±  30 /LM 
unlabeled  taxol was added. After a further 60-min  incubation  at 37°C,  cells 
were washed  five times  with 2 ml of ice-cold  PBS, and lysed in 1 ml of 0.1 N 
NaOH. Radioactivity and protein concentration were determined as described 
in Materials and Methods. Values are the average of six determinations 4- one 
standard  deviation. ATP levels  were determined for confluent 35-mm  dishes 
as described  in Materials and Methods. 
692  THE  )OURNAI. OF  CELL BIOLOGY. VOLUM~ 94, 1982 cellular  microtubules  as seen by tubulin immunofluorescence 
(data  not  shown;  16).  However,  under  conditions  in  which 
taxol induces microtubule bundles that are independent of an 
organizing center in control cells (Fig.  7 b), no such alteration 
is seen in the tubulin cytoskeleton of azide-treated cells (Fig. 7 
a). Similar observations have been made by De Brabander and 
associates  in  the  PtK2  cell  line  (M.  De  Brabander,  personal 
communication). 
Effect of 0.1% NP-40 Extraction and Calcium 
Treatment on [ 3H]Taxol Binding 
Extraction of cells with nonionic detergents such as NP-40 
or Triton X-100 releases most cellular lipid and soluble protein 
(28),  including  unassembled  tubulin  (19).  The  remaining  cy- 
toskeletal  structure  consists  mainly  of various  filaments  and 
microtubules, and their associated proteins (52, 53). If [3H]taxol 
is  allowed  to  bind  directly  to  such  cytoskeletons,  a  major 
fraction of the binding seen with unextracted  cells is retained 
(Table III).  Since these cytoskeletons have been washed free of 
their  dimer  pool,  unassembled  tubulin  does  not  appear  to 
contribute  to the binding of [3H]taxol,  and thus it is unlikely 
that the addition of 0.3 #M [3H]taxol  to intact cells is affecting 
the extent  of microtubule  polymerization.  This also  supports 
our in vitro demonstration that taxol binding is not dependent 
on microtubule treadmilling of a free tubulin dimer pool (41); 
there is a taxol-binding site on the microtubule. 
If the  cytoskeleton  is  extracted  in  the  presence  of  5  mM 
CaC12, -70%  of the specific binding is lost without an appre- 
ciable  change  in  nonspecific  binding  (Table  III).  Calcium 
extraction disrupts the microtubule cytoskeleton in these prep- 
arations (Fig. 7 c; 51). SDS polyacrylamide gel analysis of these 
extracts reveals a band comigrating with bovine brain tubulin 
in the calcium extract but not in the control (data not shown); 
the  calcium  treatment  facilitates  the  release  of tubulin  (57). 
Thus, when the calcium concentration is increased,  the result- 
ing  release  of tubulin  causes  a  disruption  of the microtubule 
F~GURE  7  Tubulin  immunofluorescence  of  J774.2  cells  after  treat- 
ment with  sodium  azide, or extraction with calcium.  (A)  Cells were 
incubated  for  60  rain  at  37°C  in  SB  containing  10  mM  NAN3,  this 
buffer was  removed,  and  fresh  SB containing  10 mM  NaN~  and  30 
laM  unlabeled  taxol  was  added  for  a  further  60-rain  incubation  at 
37°C.  (B)  Cells were incubated  for 60 min  at 37°C in  SB alone,  this 
buffer was removed, and fresh SB containing 30#M  unlabeled  taxol 
was  added  for  a  further  60-min  incubation  at  37°C.  Cells  were 
processed  for  immunofluorescence  as  described  in  Materials  and 
Methods.  (C)  Cells  were  washed  twice  at  room  temperature  with 
SB and  then  extracted  for  5  rain  at  37°C  with  SB containing  0.1% 
NP-40 and  5  mM  CaCl2.  Cells  were subsequently  washed  twice  at 
room  temperature  with  SB  and  the  extraction  procedure  was  re- 
TABLE  III 
Effect of 0.1% NP-40 Extraction on Binding of [SH]Taxol to 
]774.2 
Nonspecific  Specific 
pmol/ mg  pmol/ mg 
protein  protein 
Unextracted cell  5.1  __- 1.1  18.7 +  2.0 
Ca++-treated  unextracted  cell  7.5 +  0.4  18.2 ±  2.6 
Cytoskeleton  4.6 ±  1.1  17.0 ±  1.3 
Ca++-treated  cytoskeleton  4.6 _  0.4  6.2 ±  1.2 
Subconfluent 35-mm dishes of J774.2 were washed  twice at room temperature 
with 2 ml of stabilization  buffer (SB) and then incubated  for 5 rain at 37°C 
with 1 ml of SB alone (unextracted cells),  SB containing 5 mM CaCI2 (Ca  ÷+- 
treated  unextracted cells),  SB containing 0.1% NP-40  (cytoskeletons),  or SB 
containing  0.1% NP-40 and 5 mM CaCI2 (Ca++-treated  cytoskeletons). Cells 
were subsequently washed  twice at room  temperature with 2 ml of SB and 
the extraction procedure was repeated.  After two additional washes with SB 
at  room  temperature,  the  dishes  were  further  incubated  with  2  ml  of  SB 
containing 0.3/zM [3H]taxol 4- 30/~M unlabeled taxol for45 min at 37°C. Cells 
were washed  four times  with 2 ml of SB at room temperature, and lysed in 1 
ml of 0.1 N NaOH. Radioactivity and protein concentration were determined 
as described  in Materials and Methods. Since NP-40 extraction releases two- 
thirds  of the cellular  protein  (28),  the bound  radioactivity  in  the extracted 
samples was related  to the amount of protein in the unextracted cell  samples. 
Values are the average of six determinations  _+ one standard deviation. 
peated. Cells were processed  for immunofluorescence  as described 
in Materials and  Methods. The arrows  in  c  point to the limits of the 
cell.  Bar, 20/~m. 
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[3H]taxol.  The  specific binding  of [aH]taxol remaining  after 
calcium extraction (Table  III) is probably due either to ceils 
which are not completely lysed or to extracted cells in which 
the microtubules are not totally depolymerized. 
In contrast to intact ceils, treatment of cytoskeletons with 0.3 
#M [aH]taxol in the presence of 30 gM unlabeled taxol for 60 
min does not alter the tubulin cytoskeletal organization as seen 
by tubulin immunofluorescence. The organizing center remains 
visible and no bundle formation occurs. An intact cell appears 
to be necessary for this unusual cytoskeletal rearrangement to 
occur. 
DISCUSSION 
All of the effects of taxol in cells appear to be related specifi- 
cally to the tubulin-microtubule system. Taxol added to PtK1 
cells  at anaphase retards chromosome movement and blocks 
spindle elongation (8). Taxol-resistant Chinese hamster ovary 
(CHO) cells have an altered a-tubulin (9), while taxol requiring 
CHO cells  have a  normal cytoplasmic microtubule  complex 
but have an impaired  ability  to form a  mitotic spindle  (10). 
The migration of 3T3 cells through gold particles (48) as well 
as chemotaxis in rabbit leukocytes (38)  is inhibited  by taxol. 
Taxol injected into unfertilized Xenopus eggs induces asterlike 
tubulin  structures  (25).  In unfertilized  sea urchin eggs, taxol 
likewise  induces the formation of punctate  microtubule-con- 
taining asters.  In fertilized eggs, the sperm aster is incompetent 
to complete migration of the egg nucleus (46).  Taxol inhibits 
the growth factor-induced deciliation of primary cilia in 3T3 
ceils  (61).  It induces postmitotic myoblasts to assemble inter- 
digitating  microtubule-myosin arrays that exclude actin fila- 
ments (3).  In the trypanosome,  Trypanosoma cruzL taxol in- 
hibits cytokinesis, yet duplication of cellular organeUes contin- 
ues  (5).  The  drug  induces  abnormal  microtubule  arrays  in 
primary mouse dorsal root ganglion-spinal cord cultures (33). 
Taxol has no effect on the uptake of nucleotides, glucose, or 
amino acids in primary mouse embryo ceils  (13),  nor on the 
synthesis of DNA, RNA, or protein in exponentially growing 
HeLa cells (47) or J774.16 macrophagelike cells (26). The drug 
has no effect on ~25I-thrombin and EzSI-EGF (epidermal growth 
factor)  binding to specific surface receptors and  their  subse- 
quent internalization in primary mouse embryo cells (13). No 
alteration of Fc-mediated phagocytosis in J774.16 cells occurs 
(26). 
In vitro, taxol does not influence actin polymerization nor 
does it bind to intermediate filaments or DNA (41). The drug 
also does not affect the interaction of microtubules with their 
associated proteins in vitro (27, 50, 62) or in cells (14). Taxol 
assembles highly purified tubulin, and these microtubules bind 
[3H]taxol and are relatively stable to podophyllotoxin-induced 
disassembly (41, 50). 
Our experiments demonstrate a single set of saturable,  spe- 
cific binding  sites  for taxol  in  cells.  Since  conditions  which 
depolymerize microtubules in cells inhibit binding of [3H]taxol, 
it  is suggested that  this  single set of sites  represents  cellular 
tubulin in its polymerized form. Binding to the J774.2 cell line 
saturates at 21 pmol taxol/mg total cellular protein. Assuming 
1 mol of taxol bound/mol of polymerized tubulin (41), simple 
calculations  reveal  that  0.3%  of the  total  cellular  protein  is 
tubulin in the polymer form. Such a value is well within the 
range of total tubulin content reported for human peripheral 
unseparated monocytes (0.6%) and purified lymphocytes (0.4%; 
54), as well as guinea pig peritoneal macrophages (0.3%, 43). 
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Its limited solubility in aqueous solution and its  molecular 
structure suggest that taxol is hydrophobic and hence is prob- 
ably transported across the plasma membrane by passive dif- 
fusion. It is reasonable that the specific binding of taxol to the 
microtubule,  a  cytoplasmic  receptor,  results  in  a  saturating 
binding curve for the drug (Fig.  2  a).  Since the binding of 
[3H]taxol  saturates,  is diluted by an excess of unlabeled taxol, 
and  is  inhibited  by conditions which depolymerize microtu- 
bules, it is unlikely that the specific binding of the drug reflects 
its  partitioning  into  the  cell  membrane  or  cellular  interior. 
Thus, taxol binds directly to the preexisting cytoplasmic micro- 
tubule complex (CMTC; Table III). It does not bind vinblas- 
tine-induced paracrystals (Fig. 4), but, rather, specifically rec- 
ognizes the microtubule. 
In the original studies with taxol,  Schiff and  Horwitz (48) 
used  primary  BALB/c fibroblasts  in  which  it  is  difficult  to 
identify  a  microtubule  organizing center.  Bundle  formation 
was demonstrated but it was difficult to discern whether these 
bundles were MTOC-associated. DeBrabander et al. (18), using 
a cell line with a more prominent MTOC (PtK2),  were able to 
definitively  observe  bundles  independent  of the  organizing 
center.  Using 3T3 cells  and colcemid reversal,  Simone et al. 
(55) corroborated this finding. Our studies here with the J774.2 
cell  line  concur.  The  clearly  visualized  organization  of the 
macrophage cytoskeleton makes it an ideal tool for such study. 
The  mechanism  of microtubule  bundle  formation  is  not 
clear.  This taxol-induced process requires ATP (Table  II) as 
well as an intact, unextracted cell (Table III). Since conditions 
for  in  vitro  microtubule  bundle  formation  have  yet  to  be 
identified, it is likely that there are specific cellular conditions 
which are necessary for this unusual cytoskeletal reorganiza- 
tion. De Brabander et al. (18) have studied the time course of 
taxol-induced cytoskeletal rearrangements in control and no- 
cadazole-reversed PtKz cells visualized by peroxidase-antiper- 
oxidase immunostaining. They suggest that, in fact, the preex- 
isting  tubulin  cytoskeleton  depolymerizes  as  bundles  form. 
This idea is supported by our observation that depolymeriza- 
tion  of the  CMTC  appears  to  facilitate  bundle  formation. 
Treatment  with  0.3  #M  taxol  for  60  min  does  not  induce 
bundles in J774.2 (Fig. 5 a).  However, if the CMTC is depo- 
lymerized by nocodazole, washed,  and  0.3  gM taxol is  then 
added, bundles do form within 60 min (Fig. 6 b). Simone et al. 
(55) using colcemid reversal have reported similar results. 
Depletion of cellular ATP can inhibit depolymerization by 
colchicine or vinblastine, but does not affect repolymerization 
after nocodazole reversal (6, 17, 36). Since ATP is also required 
for taxol-induced bundle formation, it is interesting to speculate 
that microtubule depolymerization may be an important part 
of the cytoskeletal reorganization caused by taxol. In vitro data 
demonstrating that taxol suppresses microtubule treadmilling 
(27, 59) would tend to discredit depolymerization as an inter- 
mediate step in bundle formation. As yet, however, treadmill- 
ing of microtubules in cells has not been demonstrated, nor is 
it unreasonable to envisage unique cellular mechanisms that 
could overcome taxol-induced microtubule stability. 
In conclusion, we have shown that  taxol binds  to cellular 
microtubules and that such binding of taxol and subsequent 
bundle formation are related but separable events. Extraction 
with  NP-40 or treatment  with  azide  inhibits  the cytoskeletal 
reorganization without affecting the binding of [aH]taxol.  Fur- 
ther studies of conditions such as these may prove helpful in 
elucidating how the binding of this low molecular weight plant 
alkaloid  can  mediate  a  major  rearrangement  of the  cellular tubulin cytoskeleton.  Indeed, an understanding of this process 
will further  our  knowledge  of the  regulation  of microtubule 
assembly and organization  in cells.  In addition,  the  ability of 
[3H]taxol  to  stoichiometricaUy  bind  to  cellular  microtubules 
may prove  to  be  an  ideal assay  for quantifying tubulin in its 
polymer  form in cells.  Such  an  assay  is sorely  lacking in the 
current  arsenal  of microtubule  technology  and is necessary  if 
we  are  to  satisfactorily  answer  key  questions  concerning  the 
role of the tubulin polymer-dimer  equilibrium in a  variety  of 
cellular functions. 
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